EP0188595A1 - A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof - Google Patents
A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereofInfo
- Publication number
- EP0188595A1 EP0188595A1 EP19850903893 EP85903893A EP0188595A1 EP 0188595 A1 EP0188595 A1 EP 0188595A1 EP 19850903893 EP19850903893 EP 19850903893 EP 85903893 A EP85903893 A EP 85903893A EP 0188595 A1 EP0188595 A1 EP 0188595A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- drug
- composition according
- kit
- drug kit
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8403912A SE8403912D0 (sv) | 1984-07-30 | 1984-07-30 | Lekemedelssats eller -komposition |
SE8403912 | 1984-07-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0188595A1 true EP0188595A1 (en) | 1986-07-30 |
Family
ID=20356627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19850903893 Withdrawn EP0188595A1 (en) | 1984-07-30 | 1985-07-30 | A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0188595A1 (sv) |
JP (1) | JPS61502821A (sv) |
AU (1) | AU4671385A (sv) |
CA (1) | CA1246449A (sv) |
SE (1) | SE8403912D0 (sv) |
WO (1) | WO1986000812A1 (sv) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939146A (en) * | 1987-01-29 | 1990-07-03 | Kramer Richard S | Method for alleviating ischemic-reperfusion injury |
ES2007994A6 (es) * | 1988-08-16 | 1989-07-01 | Grino Boira Jose Maria | Medio liquido para perfusion y preservacion de organos. |
CH683485A5 (fr) * | 1990-11-20 | 1994-03-31 | Pasteur Merieux Serums Vacc | Solutions de perfusion, de conservation et de reperfusion d'organes. |
WO1994008612A1 (en) * | 1992-10-22 | 1994-04-28 | Thomas Peter G | New method of protecting central nervous system against damage resulting from cerebrovascular or neuronal compromise |
US6265385B1 (en) | 1996-01-11 | 2001-07-24 | Topo Target Aps | Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy |
WO1997025044A1 (en) * | 1996-01-11 | 1997-07-17 | Peter Buhl Jensen | Topoisomerase ii poison and bis-dioxypiperazine derivative combination therapy |
US5834178C1 (en) * | 1997-07-09 | 2002-04-23 | Univ Wayne State | Flush-storage solution for donor organs |
US6977140B1 (en) | 1998-09-29 | 2005-12-20 | Organ Recovery Systems, Inc. | Method for maintaining and/or restoring viability of organs |
DE69941362D1 (de) * | 1998-09-29 | 2009-10-15 | Organ Recovery Systems Inc | Vorrichtung und verfahren zur erhaltung und/oder wiederherstellung der lebensfähigkeit von organen |
US6485959B1 (en) | 1998-10-07 | 2002-11-26 | Cedars Sinai Medical Center | Cell preconditioning and cryopresevation medium |
JP2001026536A (ja) * | 1999-05-10 | 2001-01-30 | Nikken Kasei Kk | ラジカルスカベンジャー |
US6492103B1 (en) | 2000-01-31 | 2002-12-10 | Organ Recovery Systems, Inc. | System for organ and tissue preservation and hypothermic blood substitution |
WO2007105179A1 (en) * | 2006-03-15 | 2007-09-20 | Universitat Bern | Cardioplegic solution |
PT2328593E (pt) * | 2008-08-22 | 2015-04-13 | Universität Bern | Preparação cardioplégica |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2532183C3 (de) * | 1975-07-18 | 1982-03-04 | Behringwerke Ag, 3550 Marburg | Polyionische isotonische Salzlösung zur Konservierung von Erythrozyten oder zur Perfusion und zur Konservierung von zur Transplantion bestimmter Organen |
CH639270A5 (de) * | 1978-12-14 | 1983-11-15 | Koehler Franz Dr Chemie Kg | Protektive loesung fuer herz und niere. |
FR2490963B1 (fr) * | 1980-09-30 | 1986-04-18 | Science Union & Cie | Nouvelle composition therapeutique a action anti-ischemique contenant de la trimethoxy 2, 3, 4-benzyl 1-piperazine |
ATE11736T1 (de) * | 1980-12-23 | 1985-02-15 | Dr. Franz Koehler Chemie Gmbh | Protektive loesung fuer herz und niere und verfahren zu deren herstellung. |
SE8200252L (sv) * | 1982-01-18 | 1983-07-19 | Pharmacia Ab | Farmaceutisk komposition |
GB8308126D0 (en) * | 1983-03-24 | 1983-05-05 | Bloch M | Pharmaceutical compositions |
-
1984
- 1984-07-30 SE SE8403912A patent/SE8403912D0/sv unknown
-
1985
- 1985-07-29 CA CA000487656A patent/CA1246449A/en not_active Expired
- 1985-07-30 AU AU46713/85A patent/AU4671385A/en not_active Abandoned
- 1985-07-30 WO PCT/SE1985/000296 patent/WO1986000812A1/en not_active Application Discontinuation
- 1985-07-30 EP EP19850903893 patent/EP0188595A1/en not_active Withdrawn
- 1985-07-30 JP JP50341185A patent/JPS61502821A/ja active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO8600812A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1986000812A1 (en) | 1986-02-13 |
CA1246449A (en) | 1988-12-13 |
SE8403912D0 (sv) | 1984-07-30 |
AU4671385A (en) | 1986-02-25 |
JPS61502821A (ja) | 1986-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Allen et al. | Neuropeptide Y (NPY) reduces myocardial perfusion and inhibits the force of contraction of the isolated perfused rabbit heart | |
EP0188595A1 (en) | A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof | |
Gauthier et al. | Acute and chronic cardiovascular effects of 6-hydroxydopamine in dogs | |
US4675185A (en) | Solution for stabilizing red blood cells during storage | |
KR101160198B1 (ko) | 췌장 소도의 분리방법 | |
JPH09500380A (ja) | 組織保存及び無血手術のための溶液、ならびにそれを用いた方法 | |
JP2009131669A (ja) | 単一容器中にある重炭酸塩ベースの溶液 | |
Yang et al. | Haemoperfusion treatment in pigs experimentally intoxicated by paraquat | |
Laurant et al. | Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats | |
Acar et al. | Studies of controlled reperfusion after ischemia: XIX. Reperfusate composition: Benefits of blood cardioplegia over Fluosol DA cardioplegia during regional reperfusion—Importance of including blood components in the initial reperfusate | |
US7270833B2 (en) | Cardioplegic solution | |
EP0085033A1 (en) | A pharmaceutical composition | |
CN100394924C (zh) | 一种高渗液药物组合物在制备麻醉前使用的药物中的应用 | |
US6380254B2 (en) | Method and composition for treating and preventing pathogenic effects caused by intracellular calcium overload | |
Silberschmid et al. | Circulatory effects of acute lactic acidosis in dogs prior to and after hemorrhage | |
US5256660A (en) | Synthetic buffer composition for clinical use | |
US4049795A (en) | Treatment of hemorrhagic shock | |
Ballinger et al. | Anaerobic metabolism of heart | |
MacCanon et al. | Effect of bilateral cervical vagotomy in the dog | |
US11185574B2 (en) | Protective solution for preventing or reducing reperfusion injury of the brain and the whole body | |
RU2815501C1 (ru) | Раствор для предтрансплантационной подготовки донорских легких | |
SU1395251A1 (ru) | Способ консервации трупа | |
JPS6112626A (ja) | 血液保存剤 | |
Sivaramakrishna et al. | Accumulation of Norepinephrine (NE) by Rat Organs in vivo | |
Rao et al. | Effects of metabolic stimulation on cardiac allograft recovery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19860311 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
R17P | Request for examination filed (corrected) |
Effective date: 19860806 |
|
17Q | First examination report despatched |
Effective date: 19880829 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19890309 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ARFORS, KARL-ERIK Inventor name: GERDIN, BENGT |